Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | AGER | Q15109 | 1/20 | 0.33 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA5A | P35218 | 2/20 | 0.31 |
| ▸ | CA7 | P43166 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3202885 | 0.83 | LMNA (0.35) | SMN1; SMN2ALDH1A1MAPTKDM4EGAA | |
| SCHEMBL182553 | 0.77 | ALDH1A1 (0.54) | SMN1; SMN2ALDH1A1MAPTKDM4EVCAM1 | |
| SCHEMBL4613713 | 0.77 | APOBEC3G (0.54) | SMN1; SMN2ALDH1A1MAPTKDM4EGAA | |
| SCHEMBL3181881 | 0.76 | TAS2R14 (0.58) | SMN1; SMN2ALDH1A1GAALMNATAS2R14 | |
| SCHEMBL12989147 | 0.74 | SMN1; SMN2 (0.50) | SMN1; SMN2ALDH1A1MAPTKDM4EGAA | |
| SCHEMBL11135901 | 0.74 | TSHR (0.50) | SMN1; SMN2ALDH1A1MAPTKDM4EGAA | |
| SCHEMBL2936178 | 0.74 | SMN1; SMN2 (0.50) | SMN1; SMN2ALDH1A1MAPTKDM4EGAA | |
| SCHEMBL2332262 | 0.74 | SMN1; SMN2 (0.59) | SMN1; SMN2ALDH1A1MAPTKDM4EGAA | |
| SCHEMBL517898 | 0.73 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL1085990 | 0.72 | LMNA (0.64) | SMN1; SMN2ALDH1A1MAPTLMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7678907-B2 | Halogenation of rylen-carboximides with elementary halogen in a two-phase mixture comprising an organic solvent and water, wherein formed halogen hydroxide is continuously removable from the organic solvent | BASF AKTIENGESSELLSCHAFT (DE) | 2010-03-16 | — | — | US | disclosed |
| EP-1802622-B1 | HALOGENATION OF RYLEN-CARBOXIMIDES WITH ELEMENTARY HALOGEN IN A TWO-PHASE MIXTURE COMPRISING AN ORGANIC SOLVENT AND WATER, WHEREIN FORMED HALOGEN HYDROCIDE IS CONTINUOUSLY REMOVABLE FROM THE ORGANIC SOLVENT | BASF SE (DE) | 2008-04-23 | — | — | EP | disclosed |
| US-20080058526-A1 | Halogenation of Rylen-Carboximides with Elementary Halogene in a Two-Phase Mixture Comprising an Organic Solvent and Water, Wherein Formed Halogene Hydrocide is Continously Removable from the Organic Solvent | BASF AKTIENGESELLSCHAFT (DE) | 2008-03-06 | — | — | US | disclosed |
| EP-1802622-A1 | HALOGENATION OF RYLEN-CARBOXIMIDES WITH ELEMENTARY HALOGEN IN A TWO-PHASE MIXTURE COMPRISING AN ORGANIC SOLVENT AND WATER, WHEREIN FORMED HALOGEN HYDROCIDE IS CONTINUOUSLY REMOVABLE FROM THE ORGANIC SOLVENT | BASF AKTIENGESELLSCHAFT (DE) | 2007-07-04 | — | — | EP | disclosed |
| WO-2006037539-A1 | HALOGENATION OF RYLEN-CARBOXIMIDES WITH ELEMENTARY HALOGEN IN A TWO-PHASE MIXTURE COMPRISING AN ORGANIC SOLVENT AND WATER, WHEREIN FORMED HALOGEN HYDROCIDE IS CONTINUOUSLY REMOVABLE FROM THE ORGANIC SOLVENT | BASF AKTIENGESELLSCHAFT (DE) | 2006-04-13 | — | — | WO | disclosed |
| US-6190824-B1 | POLYMERIZABLE MONOMER, A PHOTOPOLYMERIZATION INITIATOR, AND A DIAZONIUM SALT HAVING A SPECIFIC, BORON ANION PORTION | FUJI PHOTO FILM CO., LTD. (JP) | 2001-02-20 | — | — | US | disclosed |
| US-5663386-A | REACTION WITH AQUEOUS ALKALINE SOLUTION PRODUCES COLOR WHICH PASSES INTO AQUEOUS PHASE | BASF AKTIENGESELLSCHAFT (DE) | 1997-09-02 | — | — | US | disclosed |
| EP-0689575-B1 | ANTHRAQUINONES AS MARKING AGENTS FOR MINERAL OILS | BASF AG (DE) | 1997-02-05 | — | — | EP | disclosed |
| EP-0689575-A1 | ANTHRAQUINONES AS MARKING AGENTS FOR MINERAL OILS | BASF AG (DE) | 1996-01-03 | — | — | EP | disclosed |
| WO-1994021752-A1 | ANTHRAQUINONES AS MARKING AGENTS FOR MINERAL OILS | BASF AKTIENGESELLSCHAFT (DE) | 1994-09-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080058526-A1 | Halogenation of Rylen-Carboximides with Elementary Halogene in a Two-Phase Mixture Comprising an Organic Solvent and Water, Wherein Formed Halogene Hydrocide is Continously Removable from the Organic Solvent | CYP8B1, HACL2, CTRB2 | SMN1; SMN2 3469/4885ALDH1A1 1379/4885MAPT 4697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.